Dementia

SuperAgers Kept Youthful Memory With Preserved Cortex and Larger Entorhinal Neurons

by
SuperAgers Reveal Biology of Preserved Memory

SuperAgers Reveal Brain Biology of Preserved Memory TL;DR: Octogenarians who recall words like 50-year-olds carry a distinct brain profile: preserved cortical volume, a cingulate cortex thicker than younger adults, larger entorhinal neurons, fewer inflammatory microglia, and more von Economo neurons — the biology is real, not just motivational. Key Findings Age-80 memory matched 50-to-60-year-olds: SuperAgers …

Read more

Lifetime Cognitive Enrichment Delayed Alzheimer’s Dementia

by
Lifetime Cognitive Enrichment Delayed Alzheimer's Dementia

Lifetime Cognitive Enrichment Delayed Alzheimer’s Dementia TL;DR: In 1,939 Rush Memory and Aging Project participants, higher lifetime cognitive enrichment was linked to 38% lower Alzheimer’s dementia hazard and about 5 years later dementia onset. Key Findings 1,939 dementia-free adults: Participants were older adults from Northeastern Illinois in the Rush Memory and Aging Project, with a …

Read more

L-DOPA Partly Rescued Entorhinal Memory Failure in Alzheimer’s Mice

by
Dopamine Disruption May Start Alzheimer's Memory Failure

Dopamine Disruption May Start Alzheimer’s Memory Failure TL;DR: In an Alzheimer’s mouse model, early memory failure tracked a broken dopamine signal into the lateral entorhinal cortex, and both optogenetic dopamine reactivation and L-DOPA partially restored learning. Key Findings Early learning slipped: Young APP knock-in mice reached 78.6% correct trials in the final learning block, compared …

Read more

Alzheimer’s Treatment Needs More Than Amyloid Drugs

by
Alzheimer's Treatment Needs More Than Amyloid

Alzheimer’s Treatment Needs More Than Amyloid TL;DR: A 2026 review in Science China Life Sciences argues that amyloid-beta antibodies such as lecanemab and donanemab are important progress, but Alzheimer’s treatment cannot stop at amyloid. The disease also involves tau tangles, genetics, aging biology, immune changes, vascular and metabolic health, and systemic conditions that shape whether …

Read more

Alpha-Synuclein Testing via Spinal Fluid Could Clarify Lewy Body Dementia Diagnosis

by
Alpha-Synuclein Testing Could Clarify Dementia Diagnosis

Alpha-Synuclein Testing Could Clarify Dementia Diagnosis TL;DR: In 398 memory-clinic patients, alpha-synuclein seed testing identified Lewy body dementia with 95% sensitivity and revealed hidden synuclein positivity in 15.8% of Alzheimer’s disease cases. Key Findings Seed testing separated Lewy body dementia: The ALZAN cohort recruited memory-clinic patients from Montpellier, Nimes, and Perpignan between November 2022 and …

Read more

Caffeinated Coffee Linked to Lower Dementia Risk Over 43 Years

by
Daily Caffeinated Coffee Linked to Lower Dementia Risk

Caffeinated Coffee Linked to Lower Dementia Risk Over 43 Years TL;DR: Caffeinated coffee drinkers had 141 vs 330 dementia cases per 100,000 person-years in the highest versus lowest intake quartiles — across 131,821 adults followed up to 43 years. Decaf showed no comparable signal. Key Findings Caffeinated coffee: 141 vs 330 dementia cases per 100,000 …

Read more

Broken Blood Vessels May Drive Alzheimer’s Decline

by

Broken Blood Vessels May Drive Alzheimer’s Decline TL;DR: A new study reveals that impaired cerebrovascular function—the brain’s ability to regulate blood flow—correlates strongly with Alzheimer’s symptoms, offering a potential non-invasive way to detect early cognitive decline. Alzheimer’s disease has long been framed as a problem of toxic protein accumulation: amyloid plaques and tau tangles strangling …

Read more

How Lecanemab Clears Amyloid: The Microglia & SPP1 Mechanism

by

How Lecanemab Clears Brain Amyloid: The Microglia Key TL;DR: Lecanemab, the first Alzheimer’s antibody to slow cognitive decline, works by activating immune cells called microglia through a specific immune signaling pathway, with the molecule SPP1/osteopontin playing a critical role in triggering the brain’s own cleanup machinery. When lecanemab was approved by the FDA, it sparked …

Read more

Cell-Type Gene Networks Reveal Hidden Causes of Alzheimer’s

by

Cell-Type Gene Networks Reveal Hidden Causes of Alzheimer’s TL;DR: Researchers mapped how genes are regulated differently across six brain cell types in Alzheimer’s disease, discovering that excitatory neurons drive the most extensive regulatory disruptions—and identifying key hub genes like RPS27A that could become therapeutic targets. Alzheimer’s disease is a disease of broken communication. The brain …

Read more

TDP43 Failure Disrupts DNA Repair in ALS and FTD

by

The Broken Repair Crew: How TDP43 Sabotages Genome Stability TL;DR: TDP43, the protein that misfires in ALS and FTD, secretly controls DNA repair genes—and when it breaks, mutations pile up in neurons, potentially explaining both neurodegeneration and the cancer link in these diseases. A protein known for its role in neurodegenerative disease has a hidden …

Read more

+ Load more